Finasteride product
Reason category: cGMP deviations
FDA recall number D-0262-2025
Prostate
Finasteride 5 mg tablet
Public data on finasteride from CMS and FDA: what pharmacies have paid for it, how many generic applications FDA has approved, and whether it appears in FDA's shortage or recall records.
$0.0686
NADAC per ea (2026-11)
approximate acquisition cost, not a retail price
-7%
change over five years
peak $0.2443 in 2014-02
22
approved generic applications (ANDAs) on record for Finasteride
14 with a product still marketed · first 2006
Not listed
in FDA's current shortage list
no matching FDA shortage entries
NADAC per unit, monthly
FINASTERIDE 5 MG TABLETShow as table
| Month | NADAC per unit ($) |
|---|---|
| 2013-11 | 0.17591 |
| 2014-02 | 0.24433 |
| 2014-05 | 0.16963 |
| 2014-08 | 0.16312 |
| 2014-11 | 0.15665 |
| 2015-02 | 0.16880 |
| 2015-05 | 0.15675 |
| 2015-08 | 0.14378 |
| 2015-11 | 0.12956 |
| 2016-02 | 0.12484 |
| 2016-05 | 0.14447 |
| 2016-08 | 0.12610 |
| 2016-11 | 0.11823 |
| 2017-02 | 0.11185 |
| 2017-05 | 0.10455 |
| 2017-08 | 0.10009 |
| 2017-11 | 0.09454 |
| 2018-02 | 0.09135 |
| 2018-05 | 0.08990 |
| 2018-08 | 0.08671 |
| 2018-11 | 0.08417 |
| 2019-02 | 0.08017 |
| 2019-05 | 0.07885 |
| 2019-08 | 0.08087 |
| 2019-11 | 0.09051 |
| 2020-02 | 0.09588 |
| 2020-05 | 0.09388 |
| 2020-08 | 0.08930 |
| 2020-11 | 0.07689 |
| 2021-02 | 0.07674 |
| 2021-05 | 0.07854 |
| 2021-08 | 0.07655 |
| 2021-11 | 0.07369 |
| 2022-02 | 0.07534 |
| 2022-05 | 0.07285 |
| 2022-08 | 0.06869 |
| 2022-11 | 0.06309 |
| 2023-02 | 0.05942 |
| 2023-05 | 0.08473 |
| 2023-08 | 0.08156 |
| 2023-11 | 0.07307 |
| 2024-02 | 0.07253 |
| 2024-05 | 0.06436 |
| 2024-08 | 0.06593 |
| 2024-11 | 0.06395 |
| 2025-02 | 0.06739 |
| 2025-05 | 0.06955 |
| 2025-08 | 0.07053 |
| 2025-11 | 0.07051 |
| 2026-02 | 0.06932 |
| 2026-05 | 0.06961 |
| 2026-08 | 0.06831 |
| 2026-11 | 0.06864 |
Source: CMS NADAC weekly files, generic rows, monthly median of weekly averages · data as of 2026-11. Figures can change and may contain errors in the source data. Check the original source before relying on them.
Recall records mentioning finasteride
openFDA enforcement records, by year reported.
| 2025 | 1 |
| 2023 | 5 |
| 2020 | 4 |
| 2018 | 4 |
| 2017 | 1 |
| 2015 | 1 |
| 2014 | 1 |
17 records since 2012. A record is one product or lot, not one recall event. Combination products that contain finasteride are included.
What these numbers mean
NADAC is what retail pharmacies pay on average to buy the drug, published by CMS. It does not include rebates and is not what you pay at the counter. ANDA counts include all strengths and forms and applications whose products are now discontinued.
Most recent recall records
Finasteride tablets
Reason category: cGMP deviations
FDA recall number D-0516-2023
Finasteride tablets
Reason category: cGMP deviations
FDA recall number D-0477-2023
Finasteride tablets
Reason category: cGMP deviations
FDA recall number D-0390-2023
Finasteride tablets usp
Reason category: cGMP deviations
FDA recall number D-0391-2023
Not health advice. GxRadar is for general information only. Nothing here is medical, pharmacy, legal or financial advice. Do not start, stop or change any medicine based on this site. Talk to your pharmacist or prescriber about your own situation.
Articles that mention finasteride
1 GxRadar article cite or discuss this drug.